Page last updated: 2024-09-05

fiduxosin and Adenoma, Prostatic

fiduxosin has been researched along with Adenoma, Prostatic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brune, ME; Buckner, SA; Esbenshade, TA; Hancock, AA; Ireland, LM; Katwala, S; Kerwin, JF; Meyer, MD; Milicic, I; Williams, M1

Other Studies

1 other study(ies) available for fiduxosin and Adenoma, Prostatic

ArticleYear
Preclinical pharmacology of fiduxosin, a novel alpha(1)-adrenoceptor antagonist with uroselective properties.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 300, Issue:2

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Dogs; Heterocyclic Compounds, 3-Ring; Humans; In Vitro Techniques; Male; Mice; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; Prostatic Hyperplasia; Pyrimidinones; Rabbits; Radioligand Assay; Rats; Rats, Inbred SHR; Urethra; Urinary Tract; Urodynamics; Vas Deferens

2002